Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD

Background - Preventing and managing exacerbations is one major component in COPD treatment. We investigated whether EPs 7630, a herbal drug preparation from the roots of Pelargonium sidoides, could prolong time to acute exacerbation in patients with COPD stage II/III. - Methods - In this randomised...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Matthys, Heinrich (VerfasserIn) , Pliskevich, Dina A. (VerfasserIn) , Bondarchuk, Oleksandr M. (VerfasserIn) , Malek, Fathi A. (VerfasserIn) , Tribanek, Michael (VerfasserIn) , Kieser, Meinhard (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 7 March 2013
In: Respiratory medicine
Year: 2013, Jahrgang: 107, Heft: 5, Pages: 691-701
ISSN:1532-3064
DOI:10.1016/j.rmed.2013.02.011
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.rmed.2013.02.011
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0954611113000607
Volltext
Verfasserangaben:Heinrich Matthys, Dina A. Pliskevich, Oleksandr M. Bondarchuk, Fathi A. Malek, Michael Tribanek, Meinhard Kieser

MARC

LEADER 00000caa a2200000 c 4500
001 1761309099
003 DE-627
005 20240414193210.0
007 cr uuu---uuuuu
008 210625s2013 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.rmed.2013.02.011  |2 doi 
035 |a (DE-627)1761309099 
035 |a (DE-599)KXP1761309099 
035 |a (OCoLC)1341417493 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Matthys, Heinrich  |d 1935-  |e VerfasserIn  |0 (DE-588)1012764907  |0 (DE-627)699759323  |0 (DE-576)345915364  |4 aut 
245 1 0 |a Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD  |c Heinrich Matthys, Dina A. Pliskevich, Oleksandr M. Bondarchuk, Fathi A. Malek, Michael Tribanek, Meinhard Kieser 
264 1 |c 7 March 2013 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 25.06.2021 
520 |a Background - Preventing and managing exacerbations is one major component in COPD treatment. We investigated whether EPs 7630, a herbal drug preparation from the roots of Pelargonium sidoides, could prolong time to acute exacerbation in patients with COPD stage II/III. - Methods - In this randomised, double-blind, placebo-controlled clinical trial, patients were randomly allocated to oral 24-week add-on therapy with 3 × 30 drops/day EPs 7630 (n = 99) or placebo (n = 101) to a standardised baseline-treatment. Primary endpoint was time to first exacerbation of COPD. Secondary endpoints were number of exacerbations, consumption of antibiotics, quality of life, patient satisfaction, inability to work, and tolerability. - Results - Median time to exacerbation was significantly prolonged with EPs 7630 compared to placebo (57 versus 43 days, Kaplan-Maier-estimate; p = 0.005, one-sided centre-stratified log-rank test). The superiority of EPs 7630 was also confirmed in secondary endpoints, e.g., fewer exacerbations, less patients with antibiotic use, improved quality of life, higher patient satisfaction, and less days of inability to work. The incidence of minor gastrointestinal adverse events was higher in the EPs 7630 group. - Conclusions - The results demonstrate a statistically significant and clinically relevant superiority of add-on therapy with EPs 7630 over placebo and a good long-term tolerability in the treatment of moderate to severe COPD. EPs 7630 prolonged time to exacerbations and reduced exacerbation frequency and antibiotic use. Trial Registration No.: ISRCTN01681733. 
650 4 |a COPD 
650 4 |a Efficacy 
650 4 |a EPs 7630 
650 4 |a Exacerbations 
650 4 |a Herbal drug preparation 
700 1 |a Pliskevich, Dina A.  |e VerfasserIn  |4 aut 
700 1 |a Bondarchuk, Oleksandr M.  |e VerfasserIn  |4 aut 
700 1 |a Malek, Fathi A.  |e VerfasserIn  |4 aut 
700 1 |a Tribanek, Michael  |e VerfasserIn  |4 aut 
700 1 |a Kieser, Meinhard  |d 1960-  |e VerfasserIn  |0 (DE-588)103276547X  |0 (DE-627)739277766  |0 (DE-576)168963825  |4 aut 
773 0 8 |i Enthalten in  |t Respiratory medicine  |d Burlington, Mass. : Harcourt, 1999  |g 107(2013), 5 vom: Mai, Seite 691-701  |h Online-Ressource  |w (DE-627)320420973  |w (DE-600)2002557-9  |w (DE-576)103746870  |x 1532-3064  |7 nnas  |a Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD 
773 1 8 |g volume:107  |g year:2013  |g number:5  |g month:05  |g pages:691-701  |g extent:11  |a Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD 
856 4 0 |u https://doi.org/10.1016/j.rmed.2013.02.011  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0954611113000607  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210625 
993 |a Article 
994 |a 2013 
998 |g 103276547X  |a Kieser, Meinhard  |m 103276547X:Kieser, Meinhard  |d 910000  |d 999701  |e 910000PK103276547X  |e 999701PK103276547X  |k 0/910000/  |k 1/910000/999701/  |p 6  |y j 
999 |a KXP-PPN1761309099  |e 3941422014 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1761309099","physDesc":[{"extent":"11 S."}],"name":{"displayForm":["Heinrich Matthys, Dina A. Pliskevich, Oleksandr M. Bondarchuk, Fathi A. Malek, Michael Tribanek, Meinhard Kieser"]},"id":{"eki":["1761309099"],"doi":["10.1016/j.rmed.2013.02.011"]},"relHost":[{"language":["eng"],"note":["Gesehen am 21.02.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisherPlace":"Burlington, Mass.","dateIssuedDisp":"1999-","publisher":"Harcourt","dateIssuedKey":"1999"}],"title":[{"title":"Respiratory medicine","title_sort":"Respiratory medicine"}],"part":{"issue":"5","pages":"691-701","text":"107(2013), 5 vom: Mai, Seite 691-701","year":"2013","volume":"107","extent":"11"},"disp":"Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPDRespiratory medicine","id":{"zdb":["2002557-9"],"eki":["320420973"],"issn":["1532-3064"]},"pubHistory":["83.1989 -"],"recId":"320420973","physDesc":[{"extent":"Online-Ressource"}]}],"person":[{"family":"Matthys","display":"Matthys, Heinrich","role":"aut","given":"Heinrich"},{"given":"Dina A.","role":"aut","family":"Pliskevich","display":"Pliskevich, Dina A."},{"family":"Bondarchuk","display":"Bondarchuk, Oleksandr M.","role":"aut","given":"Oleksandr M."},{"family":"Malek","display":"Malek, Fathi A.","given":"Fathi A.","role":"aut"},{"family":"Tribanek","display":"Tribanek, Michael","given":"Michael","role":"aut"},{"role":"aut","given":"Meinhard","family":"Kieser","display":"Kieser, Meinhard"}],"language":["eng"],"title":[{"title_sort":"Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD","title":"Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD"}],"note":["Gesehen am 25.06.2021"],"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"7 March 2013"}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a MATTHYSHEIRANDOMISED7201